Aciphin IM Injection 500 mg/vial

Aciphin is a third-generation cephalosporin antibiotic containing Ceftriaxone Sodium (500 mg/vial). Manufactured by ACI Limited, this injectable medication costs ৳145.00 per vial. It treats bacterial infections like pneumonia, meningitis, and gonorrhea by inhibiting bacterial cell wall synthesis. Available as an IM Injection, Aciphin ensures broad-spectrum coverage against Gram-positive and Gram-negative bacteria.

Aciphin’s medical indications include lower respiratory tract infections, urinary tract infections, and surgical prophylaxis. Administered once daily (IV/IM), adults typically require 1-2 grams, while pediatric doses range from 50-75 mg/kg. Maximum daily doses vary between 2-4 grams depending on infection severity. Always continue treatment for 48 hours post-symptom resolution.

Common side effects include diarrhea, skin rashes, and elevated liver enzymes. Severe reactions like thrombocytopenia or hypersensitivity require immediate medical attention. Store vials below 30°C, away from light. Avoid use during pregnancy unless absolutely necessary, as safety remains unconfirmed. Breastfeeding mothers should exercise caution.

This Aciphin IM Injection offers cost-effective therapy with precise dosing flexibility. For alternatives, explore other Ceftriaxone Sodium brands. Always consult healthcare providers for usage guidelines and contraindications.

Adults: 1-2g daily IV/IM (max 4g). Gonorrhea: Single 250mg dose. Pediatrics: 50-75mg/kg/day (max 2g). Meningitis: 100mg/kg. Treatment duration typically 4-14 days. Administer IM Injection slowly over 2-4 minutes.

Aciphin is generally well tolerated. A few side effects such as gastro-intestinal effects including diarrhea, nausea and vomiting, stomatitis and glossitis; cutaneous reactions including rash, pruritus, urticaria, edema and erythema multiforme; hematologic reactions including eosinophilia, thrombocytopenia, leucopenia, anemia and neutropenia; hepatic reactions including elevations of SGOT or SGPT, bilirubinemia; CNS reactions including nervousness, confusion, sleep disturbances, headache, hyperactivity, convulsion, hypertonia and dizziness were reported. Local phlebitis occurs rarely following intravenous administration but can be minimized by slow injections over 2-4 minutes.

Pregnancy safety unconfirmed – use only if clearly needed. Excreted minimally in breast milk – monitor infant.

Keep epinephrine ready for anaphylaxis risk. Monitor blood counts and liver function during prolonged therapy. Use ACI Limited‘s injection under medical supervision only.

Pediatric dosing requires weight-based calculation. Adjust dose for elderly and hepatic/renal impairment. Contraindicated in preterm infants.

There is no specific antidote. Treatment of overdosage should be symptomatic.